River Road Loads Up On Cal-Maine Foods With 1.37 Million Shares in Q1

River Road Asset Management disclosed a new 1,369,522-share position in Cal-Maine Foods, estimated at $112.5 million, with quarter-end value of $108.4 million and a 1.23% weight in AUM. The filing is a bullish signal for CALM, though the article also notes headwinds including a DOJ investigation, a 15.4% year-over-year share price decline to $75.07, and falling net income as egg margins normalized. Overall, this is notable investor positioning news rather than a major fundamental catalyst.

Analysis

River Road’s buy looks less like a simple value screen and more like a bet on earnings mean reversion at the bottom of the egg cycle. The key second-order effect is that Cal-Maine’s cash generation is highly countercyclical to input-cost and pricing shocks: when grain/fertilizer or avian-flu-related supply constraints re-tighten the market, the equity can re-rate very quickly because the market is buying peak-earnings skepticism, not normalized power. That makes the position attractive if management can avoid a material regulatory overhang while preserving capital allocation discipline.

The litigation risk is the real swing factor. A DOJ probe does not need to produce a large fine to matter; it can cap the multiple by keeping investors from underwriting “normal” peak margins as durable. In the near term, the stock likely trades more on commodity and feed-cost headlines than on fundamentals, but over the next 3-6 months any bounce in egg pricing could create an outsized EPS revision cycle because the market is starting from a very low multiple.

The contrarian miss is that low P/E alone is not the catalyst; the catalyst is the spread between realized egg prices and feed costs. If that spread widens, CALM can compound through buybacks/dividends even without multiple expansion, but if supply normalizes faster than expected, the stock can stay cheap for longer. The buy by a quality value manager suggests downside may be closer to cash-flow support than the headline multiple implies, but it is not a clean “buy and forget” staple—it is a cyclical with legal risk wearing a defensive label.

Key Decisions for Investors

• Go long CALM on pullbacks, with a 3-6 month horizon: target a re-rating from depressed earnings expectations rather than multiple expansion; trim if egg prices fail to stabilize over the next quarter.
• Pair trade: long CALM / short a broader defensive consumer-staples ETF or quality staple basket, betting on cyclical EPS upside while avoiding sector-wide valuation compression.
• If you want defined risk, buy CALM call spreads 3-6 months out; use them to express a view that the market is underpricing a short-cycle earnings rebound while capping litigation headline risk.
• Avoid adding to CALM if DOJ headlines intensify or if feed-cost relief is accompanied by softening retail pricing; that combination can compress margins faster than consensus can update.